本文選題：存貨管理 + 優(yōu)化方案��； 參考：《湘潭大學》2017年碩士論文

【摘要】：醫(yī)藥行業(yè)一直被大家譽為“永遠的朝陽產(chǎn)業(yè)”,全球醫(yī)藥行業(yè)市場規(guī)模長期保持穩(wěn)定增長的趨勢。目前中國的經(jīng)濟高速發(fā)展,人們的物質(zhì)生活水平逐步提高,醫(yī)療保障制度也不斷完善,人口老齡化問題日益突出,我國醫(yī)藥行業(yè)呈現(xiàn)出持續(xù)良好的發(fā)展趨勢。但是隨著新醫(yī)改的推進,醫(yī)藥市場格局隨之巨變,醫(yī)藥行業(yè)的增速放緩,行業(yè)之間的競爭也日益激烈。在醫(yī)藥制造行業(yè)中,由于它的主營產(chǎn)品是藥品,而國家對于藥品的生產(chǎn)、儲存以及運輸都有著非常嚴格的標準,導致了存貨的管理成本較高,據(jù)統(tǒng)計醫(yī)藥制造行業(yè)的庫存成本達到了總成本的30%以上。G制藥公司的存貨周轉(zhuǎn)率遠低于行業(yè)平均值,公司的庫存囤積嚴重,影響了公司的經(jīng)營發(fā)展。因此有必要對G公司的存貨問題進行研究,以保障公司的可持續(xù)性發(fā)展。論文以G制藥公司的存貨為研究對象,通過實地考察和問卷調(diào)查了解到G公司存貨管理的現(xiàn)狀,從存貨的采購環(huán)節(jié)、驗收入庫環(huán)節(jié)、倉儲環(huán)節(jié)、發(fā)出環(huán)節(jié)以及存貨的銷售退回環(huán)節(jié)提出了公司目前存貨管理存在的問題,并對各個環(huán)節(jié)的問題逐一進行了原因分析。接著提出以下切合G公司實際情況的優(yōu)化方案:在存貨的采購環(huán)節(jié),建立供應商的績效考評機制和完善訂立合同的制度可以保證原材料的質(zhì)量和提高采購效率;在存貨的驗收入庫環(huán)節(jié),加強存貨入庫的復核工作和確保存貨及時入庫可以降低產(chǎn)品的殘次率和提高生產(chǎn)環(huán)節(jié)的效率;在存貨的倉儲環(huán)節(jié),改進倉儲方式、完善倉儲管理制度以及規(guī)范存貨盤點制度可以降低存貨的倉儲成本以及保管成本,即能提高存貨的倉儲效率;在存貨的發(fā)出環(huán)節(jié),加強存貨的出庫管理和加強第三方物流的管理,可以提高藥品的運輸效率,提高顧客的滿意度;在存貨的銷售退回環(huán)節(jié),建立完善的質(zhì)量控制體系和加強銷售退回的責任認定,能夠有效地降低產(chǎn)品的銷售退回率。最后根據(jù)內(nèi)部控制五要素對G公司存貨管理的優(yōu)化方案提出了四點保障性措施。建立完善的存貨預算制度、強化存貨風險意識、建立良好的信息交流系統(tǒng)以及加強內(nèi)部監(jiān)督、完善績效考評機制。相信本文的這些措施能夠加快G公司存貨周轉(zhuǎn)速度,提高公司的存貨管理水平,能夠有效地改善公司目前高庫存的現(xiàn)狀,使得G公司能夠在行業(yè)的競爭中具有更多的優(yōu)勢。
[Abstract]:The pharmaceutical industry has been praised as "the sunrise industry forever", the global pharmaceutical industry market scale has maintained the stable growth trend for a long time. At present, with the rapid development of China's economy, the improvement of people's material living standard, the improvement of medical security system and the aging of population, the medical industry of our country is showing a sustained and good trend of development. However, with the development of the new medical reform, the pattern of the pharmaceutical market has changed dramatically, the growth rate of the pharmaceutical industry has slowed down, and the competition between the industries has become increasingly fierce. In the pharmaceutical manufacturing industry, because its main product is medicine, and the country has very strict standards for the production, storage and transportation of drugs, the cost of inventory management is relatively high. According to statistics, the inventory cost of pharmaceutical manufacturing industry has reached more than 30% of the total cost. The inventory turnover rate of the pharmaceutical company is far below the average of the industry, and the stock hoarding of the company is serious, which affects the development of the company. Therefore, it is necessary to study the inventory problem of company G to ensure the sustainable development of the company. This paper takes the inventory of G pharmaceutical company as the research object, through the field investigation and questionnaire survey to understand the current situation of G company inventory management, from the stock procurement link, the acceptance warehousing link, the storage link, the storage link. In this paper, the problems in inventory management are put forward, and the reasons for the problems are analyzed one by one. Then it puts forward the following optimization schemes according to the actual situation of G company: in the purchasing of inventory, establishing the supplier's performance evaluation mechanism and perfecting the contract conclusion system can guarantee the quality of raw materials and improve the purchasing efficiency; In the link of stock acceptance and storage, strengthening the rechecking of inventory and ensuring the timely storage of inventory can reduce the residue rate of products and improve the efficiency of production, and improve the storage mode in the link of inventory storage. Perfecting the warehouse management system and standardizing the inventory inventory system can reduce the storage cost and the storage cost of the inventory, that is, it can improve the storage efficiency of the inventory. Strengthening the management of inventory out of stock and the management of third party logistics can improve the efficiency of drug transportation and the satisfaction of customers, establish a perfect quality control system and strengthen the recognition of the responsibility of sales return in the link of stock sale and return. Can effectively reduce the sales return rate. Finally, according to the five elements of internal control, the paper puts forward four supporting measures to the optimization scheme of inventory management in G Company. Establish a perfect inventory budget system, strengthen inventory risk awareness, establish a good information exchange system and strengthen internal supervision, improve the performance evaluation mechanism. It is believed that these measures in this paper can accelerate the inventory turnover speed of company G, improve the level of inventory management, effectively improve the current situation of high inventory, and enable company G to have more advantages in the competition of the industry.
【學位授予單位】：湘潭大學
【學位級別】：碩士
【學位授予年份】：2017
【分類號】：F426.72;F273.4

【參考文獻】

相關期刊論文 前10條

1 周顧宇;;ABC分類法在中小型商場存貨管理中的應用[J];北方經(jīng)貿(mào);2015年11期

2 文愛峗;;探討出版企業(yè)存貨管理中的問題與對策[J];財經(jīng)界(學術版);2015年21期

3 蔡亞芬;;加強存貨管理 提高企業(yè)經(jīng)濟效益[J];中國集體經(jīng)濟;2015年25期

4 申學哲;;企業(yè)存貨管理的問題與思考[J];現(xiàn)代經(jīng)濟信息;2015年10期

5 張旭侃;秦欣;;企業(yè)存貨管理中存在的問題及對策[J];商場現(xiàn)代化;2015年14期

6 李璇;;淺談如何加強企業(yè)存貨管理[J];商場現(xiàn)代化;2015年03期

7 徐穎;;企業(yè)加強存貨管理有效途徑的探討[J];東方企業(yè)文化;2014年24期

8 曹文平;陳昌明;;我國制造業(yè)存貨管理問題研究[J];商業(yè)會計;2013年15期

9 王秀華;王竹泉;秦書亞;;供應鏈核心企業(yè)營運資金管理績效的情境研究[J];財會月刊;2013年07期

10 孫效;傅帥;譚穎杰;;基層醫(yī)療單位回款難問題解析[J];中國保健營養(yǎng);2013年05期

相關碩士學位論文 前4條

1 王思卉;J醫(yī)藥公司存貨管理的內(nèi)部控制問題研究[D];南京大學;2016年

2 王婕;HB食品有限公司存貨內(nèi)部控制改進研究[D];湖南大學;2013年

3 甘泉;江森公司存貨管理研究[D];北京交通大學;2012年

4 張旭萬;存貨影響需求的供應鏈庫存模型研究[D];重慶大學;2007年

，

本文編號：1856726